Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
Clinical trial NCT07039422 · RECRUITING
Trial details
- NCT number
- NCT07039422
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2030-08-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.